National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report-Reference-Cited by-同舟云学术

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report

Published:2021-08 Issue:8 Volume:27 Page:632-641
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Pidala Joseph,Kitko Carrie,Lee Stephanie J.,Carpenter Paul,Cuvelier Geoffrey D.E.,Holtan Shernan,Flowers Mary E.,Cutler Corey,Jagasia Madan,Gooley Ted,Palmer Joycelynne,Randolph Tim,Levine John E.,Ayuk Francis,Dignan Fiona,Schoemans Helene,Tkaczyk Eric,Farhadfar Nosha,Lawitschka Anita,Schultz Kirk R.,Martin Paul J.,Sarantopoulos Stefanie,Inamoto Yoshihiro,Socie Gerard,Wolff Daniel,Blazar Bruce,Greinix Hildegard,Paczesny Sophie,Pavletic Steven,Hill Geoffrey

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference91 articles.

1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group report;Williams;Transplant Cell Ther,2021

2. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria;Flowers;Blood,2011

3. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting;Afram;Med Oncol,2018

4. Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors;Lazaryan;Biol Blood Marrow Transplant,2016

5. Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant;Watkins;Bone Marrow Transplant,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care;American Society of Clinical Oncology Educational Book;2024-06

2. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development;Current Oncology;2024-03-08

3. Novel therapies for graft versus host disease with a focus on cell therapies;Frontiers in Immunology;2023-10-05

4. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death;Journal of Clinical Investigation;2023-08-01

5. Updates in chronic graft‐versus‐host disease management;American Journal of Hematology;2023-07-22